Madrigal Pharmaceuticals MDGL
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q1 | 331.23 | 113.40 | -3.32 | -79,311 | -73 | |
| 2024Q4 | 308.57 | 119.81 | -2.59 | -66,996 | -59 | |
| 2024Q3 | 212.22 | 112.60 | -4.84 | -116,304 | -107 | |
| 2024Q2 | 280.16 | 109.59 | -7.09 | -162,538 | -152 | |
| 2024Q1 | 267.04 | 105.80 | -7.38 | -152,037 | -148 | |
| 2023Q4 | 231.38 | 108.27 | -5.72 | -117,176 | -112 | |
| 2023Q3 | 146.04 | 103.46 | -5.36 | -98,534 | -99 | |
| 2023Q2 | 231.00 | 104.28 | -4.68 | -86,450 | -86 | |
| 2023Q1 | 242.26 | 105.06 | -4.23 | -78,336 | -77 | |
| 2022Q4 | 290.25 | 101.28 | -4.98 | -85,299 | -86 | |
| 2022Q3 | 64.99 | 100.90 | -4.75 | -80,412 | -81 | |
| 2022Q2 | 71.58 | 100.46 | -4.14 | -70,273 | -71 | |
| 2022Q1 | 98.12 | 100.12 | -3.36 | -57,587 | -58 | |
| 2021Q4 | 84.74 | 100.08 | -3.79 | -64,601 | -65 | |
| 2021Q3 | 79.79 | 100.10 | -3.79 | -63,160 | -63 | |
| 2021Q2 | 97.41 | 100.15 | -3.73 | -61,742 | -62 | |
| 2021Q1 | 116.97 | 100.82 | -3.32 | -52,979 | -53 | |
| 2020Q4 | 111.17 | 100.73 | -3.82 | -59,555 | -59 | |
| 2020Q3 | 118.73 | 101.42 | -3.75 | -58,786 | -58 | |
| 2020Q2 | 113.25 | 102.66 | -3.18 | -50,327 | -49 |